Goals
  • Identify and treat underlying structural heart disease and other predisposing conditions
  • Relieve symptoms
  • Improve functional capacity/quality of life
  • Reduce morbidity/mortality associated with AF/AFL
    • Prevent tachycardia-induced cardiomyopathy
    • Reduce/prevent emergency room visits or hospitalizations secondary to AF/AFL
    • Prevent stroke or systemic thromboembolism